Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

This phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer. Bupropion hydrochloride may work by boosting sexual desire, energy, or motivation without causing intolerable or undesirable side effects.

Research Base: NRG Oncology
NCT ID: NCT03180294
NCI Protocol Number: NRG-CC004
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Bupropion Hydrochloride; Placebo

Condition

Breast Carcinoma, Cervical Carcinoma, Ovarian Carcinoma, Postmenopausal, Uterine Corpus Cancer, Vaginal Carcinoma, Vulvar Carcinoma

Trial Type

Supportive Care/Symptom Management/PROs

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP